Oramed Pharmaceuticals Inc. — Director's Dealing 2022

Feb 14, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ORAMED PHARMACEUTICALS INC. (ORMP)
CIK: 0001176309
Period of Report: 2022-02-11

Reporting Person: RAKIN KEVIN (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-02-11	Common Stock	G	5000	—	Disposed	47004	Direct

Footnotes

F1: This transaction represents a charitable donation effective February 11, 2022. This is not a market transaction, thus no price has been reported. No value was received for the donated shares.